TSE:NVLN - Novelion Therapeutics News Headlines

C$13.30
0.00 (0.00 %)
(As of 12/18/2018)
Add
Today's Range
C$13.30
Now: C$13.30
C$13.30
50-Day Range N/A
52-Week Range
C$10.68
Now: C$13.30
C$13.67
VolumeN/A
Average Volume3,220 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Novelion Therapeutics (TSE NVLN) News Headlines

Source:
DateHeadline
BRIEF-Novelion Therapeutics Says Got Letter Notifying Co That Nasdaq Has Determined To Delist Cos Common Stock From NasdaqBRIEF-Novelion Therapeutics Says Got Letter Notifying Co That Nasdaq Has Determined To Delist Co's Common Stock From Nasdaq
www.msn.com - August 21 at 8:59 PM
Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from NasdaqNovelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
finance.yahoo.com - August 21 at 8:59 PM
Novelion Therapeutics receives non-compliance notificationsNovelion Therapeutics receives non-compliance notifications
seekingalpha.com - July 5 at 11:30 AM
Novelion Therapeutics Responds to Whitefort Capital PetitionNovelion Therapeutics Responds to Whitefort Capital Petition
www.nasdaq.com - June 24 at 12:13 PM
Amryt Pharma to acquire 100% of reorganized stock of Aegerion as a result of recapitalizationAmryt Pharma to acquire 100% of reorganized stock of Aegerion as a result of recapitalization
seekingalpha.com - May 21 at 9:14 AM
Novelion Therapeutics Inc. Estimate MomentumNovelion Therapeutics Inc. Estimate Momentum
www.nasdaq.com - March 18 at 3:39 PM
AVGO, BDSI and NVLN among premarket gainersAVGO, BDSI and NVLN among premarket gainers
seekingalpha.com - March 15 at 9:31 AM
Novelion up 92% premarket on Juxtapid deal in JapanNovelion up 92% premarket on Juxtapid deal in Japan
seekingalpha.com - February 6 at 8:37 AM
Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in JapanNovelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
globenewswire.com - February 6 at 8:37 AM
50 Biggest Movers From Tuesday50 Biggest Movers From Tuesday
www.msn.com - December 7 at 3:16 PM
Brexit premium drives up euro borrowing costs for UK firms as EU exit looms'Brexit premium' drives up euro borrowing costs for UK firms as EU exit looms
www.streetinsider.com - December 6 at 5:50 AM
Pre-Open Movers 12/04: (NVLN) (RH) (CLVS) Higher; (KRNT) (CRUS) (DG) Lower (more...)Pre-Open Movers 12/04: (NVLN) (RH) (CLVS) Higher; (KRNT) (CRUS) (DG) Lower (more...)
www.streetinsider.com - December 5 at 5:43 AM
Healthcare Value CapitalHealthcare Value Capital
www.benzinga.com - December 4 at 3:16 PM
Novelion Rises 50% After Activist Investor Demands Exploration Of Strategic AlternativesNovelion Rises 50% After Activist Investor Demands Exploration Of Strategic Alternatives
www.benzinga.com - December 4 at 3:16 PM
After-Hours Movers 12/03: (NVLN) (RH) (SMAR) Higher; (CRUS) (FRAC) (UDR) Lower (more...)After-Hours Movers 12/03: (NVLN) (RH) (SMAR) Higher; (CRUS) (FRAC) (UDR) Lower (more...)
www.streetinsider.com - December 4 at 5:39 AM
Novelion Therapeutics (NVLN) Names Michael Price as SVP and CFO - StreetInsider.comNovelion Therapeutics (NVLN) Names Michael Price as SVP and CFO - StreetInsider.com
www.streetinsider.com - December 5 at 9:42 AM
Novelion Therapeutics Expands Leadership Team with Appointment of Jeffrey Hackman as Chief Operating OfficerNovelion Therapeutics Expands Leadership Team with Appointment of Jeffrey Hackman as Chief Operating Officer
www.nasdaq.com - November 1 at 7:05 AM
RSI Alert: Novelion Therapeutics (NVLN) Now OversoldRSI Alert: Novelion Therapeutics (NVLN) Now Oversold
www.thestreet.com - October 20 at 7:01 AM
Novelion Therapeutics Strengthens Leadership Team with Appointment of Murray Stewart, M.D., as Executive Vice President, Head of R&DNovelion Therapeutics Strengthens Leadership Team with Appointment of Murray Stewart, M.D., as Executive Vice President, Head of R&D
www.nasdaq.com - October 13 at 7:37 AM
Novelion Therapeutics Enters Oversold Territory (NVLN)Novelion Therapeutics Enters Oversold Territory (NVLN)
www.thestreet.com - September 20 at 7:10 AM
Noteworthy Monday Option Activity: MAC, NVLN, WATTNoteworthy Monday Option Activity: MAC, NVLN, WATT
www.thestreet.com - September 12 at 7:18 AM
Novelion Therapeutics reports 2Q loss | Fox News - Fox NewsNovelion Therapeutics reports 2Q loss | Fox News - Fox News
www.foxnews.com - August 9 at 5:41 AM
Novelion Therapeutics (NVLN) Names Mark DiPaolo to BoardNovelion Therapeutics (NVLN) Names Mark DiPaolo to Board
www.streetinsider.com - August 4 at 6:30 AM
Novelion Therapeutics (NVLN) Names Mark DiPaolo to Board - StreetInsider.comNovelion Therapeutics (NVLN) Names Mark DiPaolo to Board - StreetInsider.com
www.streetinsider.com - August 3 at 6:27 AM
Novelion Therapeutics Added to the Russell 3000® & Russell Microcap® Indexes - GlobeNewswire (press release)Novelion Therapeutics Added to the Russell 3000® & Russell Microcap® Indexes - GlobeNewswire (press release)
globenewswire.com - June 27 at 6:47 AM
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel